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Enigmatic Presence of Mitochondrial Complex I in
Trypanosoma brucei Bloodstream Forms
Sachin Surve,a Meredith Heestand,a Brian Panicucci,a* Achim Schnaufer,a,b and Marilyn Parsonsa,c
Seattle Biomedical Research Institute, Seattle, Washington, USAa; Institute of Immunology & Infection Research and Centre of Immunity, Infection & Evolution, The
University of Edinburgh, Edinburgh, United Kingdomb; and Department of Global Health, University of Washington, Seattle, Washington, USAc
The presence of mitochondrial respiratory complex I in the pathogenic bloodstream stages of Trypanosoma brucei has been vig-
orously debated: increased expression of mitochondrially encoded functional complex I mRNAs is countered by low levels of
enzymatic activity that showmarginal inhibition by the specific inhibitor rotenone. We now show that epitope-tagged versions
of multiple complex I subunits assemble into  and subcomplexes in the bloodstream stage and that these subcomplexes re-
quire the mitochondrial genome for their assembly. Despite the presence of these large (740- and 855-kDa) multisubunit com-
plexes, the electron transport activity of complex I is not essential under experimental conditions since null mutants of two core
genes (NUBM andNUKM) showed no growth defect in vitro or in mouse infection. Furthermore, the null mutants showed no
decrease in NADH:ubiquinone oxidoreductase activity, suggesting that the observed activity is not contributed by complex I.
This work conclusively shows that despite the synthesis and assembly of subunit proteins, the enzymatic function of the largest
respiratory complex is neither significant nor important in the bloodstream stage. This situation appears to be in striking con-
trast to that for the other respiratory complexes in this parasite, where physical presence in a life-cycle stage always indicates
functional significance.
Trypanosoma brucei subspecies are single-celled protozoan par-asites that cause human African trypanosomiasis, or sleeping
sickness, and a variety of related diseases in animals. Their life
cycles include development in the tsetse fly vector and a mamma-
lian host. Within the mammalian host, T. brucei bloodstream
forms (BFs) proliferate as slender forms, some of which develop
into nonproliferating stumpy forms that show specific metabolic
adaptations presaging the next developmental stage within the fly
midgut (procyclic forms [PFs]). Among the differences between
BFs and PFs are major alterations in mitochondrial metabolism
(62). For instance, PFs derive their energy mostly by proline me-
tabolism, which employs mitochondrial enzymes (14), while BFs
rely exclusively on glucose and glycolysis for their energy needs
(39). Inmany eukaryotes, the glycolytic pathway is followed by the
mitochondrial Krebs cycle, which is linked to the respiratory elec-
tron transport chain to allow the generation of many additional
ATP molecules. However, in trypanosomes as well as many other
protozoa, the situation is more complex and the Krebs cycle en-
zymes, although present, are not linked in a complete cycle.
Respiratory complexes III and IV are present and functional in
PFs but absent in BFs. In contrast, complex V is present in both
stages (5, 6, 60). While there are reports of the first enzyme com-
plex (complex I [cI]) in the respiratory chain in PFs (1, 21, 43, 61),
its presence and functionality in BFs have been debated (40).
Complex I (NADH:ubiquinone oxidoreductase [EC 1.6.5.3])
resides in the plasma membrane of prokaryotes and mitochon-
drial inner membrane of eukaryotes, where it catalyzes the oxida-
tion ofNADHand transfers electrons to coenzymeQ (23, 41). The
energy thus acquired is used to pump protons across the mem-
brane. Crystallographic studies of prokaryotic cI have shown that
the hydrophilic arm functioning in electron transfer extends into
the cytosol at a right angle to the hydrophobic, proton-pumping
arm embedded in the membrane (18, 27). Prokaryotic cI is com-
posed of 14 subunits; these subunits make up the core complex
(23). Mammalian cI additionally contains up to 32 accessory sub-
units (11), some of which are involved in assembly of the complex
(50).
Bioinformatic analyses of the T. brucei nuclear and mitochon-
drial genomes identified 19 conserved subunits of cI, but 2 core
subunits were not found: NULM (ND4L) and NU6M (ND6) (29,
40, 56, 57). These subunits reside in the hydrophobic membrane
arm and are thought to be essential for proton pumping (68).
Thus, it has been suggested that inT. brucei cI does not participate
in forming the electrochemical gradient of the mitochondrion
(40). The underlying assumption for this proposal is questioned
by recent data from the yeast Yarrowia lipolytica that suggest that
proton pumping may occur via two distinct modules (proximal
and distal) (17). This raises the possibility that T. brucei cI could
still function in that process. Adding to the controversy on the
presence of functional cI in T. brucei (40) are the high concentra-
tions of the cI inhibitor rotenone required for inhibition (raising
questions of off-target activity) and the presence of the alternative
NADH dehydrogenase NDH2 (20), which could confound enzy-
matic assays. Nonetheless, cumulative evidence now indicates the
presence of cI in PFs. First, in addition to NADH dehydrogenase
activity that is moderately sensitive to rotenone, immunodetec-
tion of cI subunits was reported (21). Second, proteomic analysis
Received 1 November 2011 Accepted 28 November 2011
Published ahead of print 9 December 2011
Address correspondence to Achim Schnaufer, achim.schnaufer@ed.ac.uk, or
Marilyn Parsons, marilyn.parsons@seattlebiomed.org.
* Present address: Biology Center, Institute of Parasitology, Ceske Budejovice,
Czech Republic.
A. Schnaufer and M. Parsons contributed equally to this article.
Supplemental material for this article may be found at http://ec.asm.org/.
Copyright © 2012, American Society for Microbiology. All Rights Reserved.
doi:10.1128/EC.05282-11
1535-9778/12/$12.00 Eukaryotic Cell p. 183–193 ec.asm.org 183
of a large complex isolated from PFs by immunoprecipitation or
tandem affinity purification (TAP) has identified several bona fide
cI subunits, including several core proteins (1, 42), although the
mitochondrially encoded proteins have not yet been detected.
Most recently, RNA interference (RNAi)-mediated knockdownof
three core subunits of cI has indicated that this complex is not
required for normal growth in cultured PFs but that it may con-
tribute approximately 20% of the total mitochondrial NADH:
ubiquinone oxidoreductase activity (61).
Thus far, there have been no reports of intact cI (or cI subcom-
plexes) in BFs. However, previous findings suggested a potential
upregulation in that stage since mRNA levels of several of the
mitochondrially encoded cI subunits were shown to be increased
compared to the levels in PFs. These include mRNAs that must
undergo RNA editing to generate a functional transcript (ND7,
ND8, ND9) (31, 49, 57), as well as those that are never edited
(ND4, ND5). Indeed, several mitochondrially encoded cI subunit
mRNAs are preferentially edited in BFs (31, 56), and the ND7
subunit is fully edited in BFs only (31, 48). Ablation of mitochon-
drial gene expression is normally lethal in BFs, demonstrating that
essential gene products are encoded in the mitochondrial DNA
(53). Therefore, we hypothesized that cI could be playing an im-
portant role in this stage of the parasite’s life cycle. Here we report
the presence of cI and cI subcomplexes in BFs. However,
knockout of two core subunits in slender-form BFs revealed that
electron transport activity of the complex was irrelevant for in
vitro or in vivo growth of the pathogen. Furthermore, NADH:
ubiquinone oxidoreductase activity was not reduced in the knock-
outmutants. Thus, our findings conclusively demonstrate that the
classical function of cI as a proton pump driven by electron trans-
port is insignificant in slender BFs.
MATERIALS AND METHODS
Parasites and growth assays. BF strain 427 T. b. brucei, its single-marker
derivative (63), andT. evansiAnTat 3/3 (55)were grown at 37°C inHMI-9
medium (25) supplemented with 10% heat-inactivated fetal bovine se-
rum (FBS). The T. evansi strain employed is a rel1 null mutant in which
the two alleles of the REL1 locus are occupied by constructs encoding the
T7 RNA polymerase and the tetracycline (Tet) repressor, respectively
(52). PF strain 29-13, expressing T7 RNA polymerase and Tet repressor,
was cultured in SDM-79 medium (JRH Biosciences [7]) with 10% heat-
inactivated FBS. Drugs tomaintain selection for transgenes were included
when relevant: G418 (2.5g/ml for BFs, 15g/ml for PFs), hygromycin (5
g/ml for BFs, 50 g/ml for PFs), and puromycin (1 g/ml for BFs and
PFs). PFs and BFs were transfected as described previously (63). Trans-
fected cells were selected in appropriate medium with drugs as described
above. Protein expression from Tet-regulated constructs was induced
with 1 to 2g/ml of Tet. A list of the cell lines used in this study is provided
in Table 1.
For analysis of growth in vitro and in vivo, wild-type (WT) 427 and
knockout lines weremaintained in logarithmic phase of growth for 2 days
before the start of the experiments (cell number not exceeding 106/ml).
For in vitro growth assays, 5 104 parasites were inoculated into 1 ml in
triplicate. Cell counts were taken every 24 h over a period of 6 days, and
cultures were split 1:20 when the number reached 106/ml.
Procedures involving vertebrate animals (rats andmice) followed pro-
tocols approved by the institutional IACUC. For in vivo assays, BALB/c
mice were infected intraperitoneally with 104 cells resuspended in 200 l
of phosphate-buffered saline (PBS) containing 10 mM glucose (PSG).
Parasitemias were scored every 12 to 24 h starting at 72 h postinfection.
Blood obtained by tail prick was diluted 200-fold in cell fix solution (3.7%
formaldehyde in 1 SSC [1 SSC is 0.15 M NaCl plus 0.015 M sodium
citrate]), and parasites were counted microscopically using a Neubauer
hemocytometer. Mice were euthanized by CO2 asphyxiation when the
parasite number exceeded 108 cells/ml.When needed, large numbers (1
109 to 3 109) of T. brucei BFs were obtained from 1 to 4 infected rats as
described previously (28). Rats were provided doxycycline in their drink-
ing water to induce expression of the tagged gene. Briefly, when the par-
asitemia reached 108/ml blood, infected blood was harvested and
pooled. The buffy coat containing the trypanosomes was loaded onto a
DE52 column, where the red blood cells were retained. The parasites were
collected from the flowthrough fraction.
Plasmids and constructs. The open reading frames of NUAM,
NUHM,NUKM,NB4M,NI2M,NI8M, the LYR4/ISD11-related gene LIR,
and acyl coenzyme A (CoA)-synthetase/ligase like gene (ACSL) were PCR
amplified using strain 427 genomic DNA as template and primers that
placed HindIII and BamHI restriction enzyme sites and AvrII and XhoI
restriction enzyme sites at the 5= and 3= ends of the amplicon, respectively
(see Table 1 for systematic identifiers and Table S1 in the supplemental
material for primers). The products were digested with the corresponding
enzymes and were cloned into the T. brucei expression vector pT7-3V5-
PAC (22), such that three V5 tags were appended to the C terminus of the
protein. TheNUBM PCRproduct was similarly cloned into pLew79-3V5-
TABLE 1 cI V5-tagged proteins and transfectants examined in this study
Name in Swiss-Prot
database (human) Systematic identifier Category Transfectant(s)
Complex
observed (kDa)
cI subcomplex
NUAM (NDUFS1) Tb927.10.12540 Core BF SMa No
NUBM (NDUFV1) Tb927.5.450 Core BF SM, BFnukm, BF T. evansi rel1, PF 29.13 740b
NUHM (NDUFV2) Tb927.7.6350 Core BF SM, BF NUBM-TAP, BF LIR-HA 740
NUKM (NDUFS7) Tb11.47.0017 Core BF SM No
NUEM (NDUFA9) Tb09.244.2620c Conserved accessory BF SM No
NI8M (NDUFA5) Tb11.01.8630 Conserved accessory BF SM 740
NB4M (NDUFA6) Tb927.10.14860 Conserved accessory BF SM 740
ACSL Tb927.6.2010 Accessory BF SM No
cI subcomplex
NI2 M (NDUFB9) Tb11.01.7460 Conserved accessory BF SM, BF NUBM-TAP, BF LIR-HA 855
LIR Tb11.01.7090 Accessory BF SM, BFnubm, BFnukm, BF T. evansi rel1, BF
NUBM-TAP, PF 29.13
855b
a SM, BF single-marker strain.
b No complex observed in T. evansi.
c One of two candidate NUEM genes, the other being Tb927.10.13620 (1).
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PAC and pT7-MH-TAP vectors. The latter was created in two steps. First,
pT7-Myc (gift of David Horn) was modified by deleting the Myc tag and
stuffer region and inserting a linker containing AvrII and NsiI sites. We
named this intermediate vector pT7-AN. Second, the sequences encoding
theMyc, His, and TAP tags of pLew79-MH-TAPwere released with AvrII
and PstI and cloned in pT7-AN digested with AvrII and NsiI. The vector
pT7-3HA-HYGwas generated by ligating a linker coding for three repeats
of the hemagglutinin (HA) peptide (YPYDVPDYA) plus HindIII, XhoI,
and BamHI sites into the AvrII and PstI sites of pT7-AN. The LIR coding
region was subcloned from pT7-LIR-V5-PAC into this vector using
HindIII and BamHI sites, to yield a C-terminally HA-tagged protein. All
relevant regions of the plasmids were confirmed by sequencing. The con-
structs were linearized by NotI digestion prior to transfection.
To generate BF cell lines lacking cI subunits, approximately 500 bp of
the 5= and 3= intergenic regions from NUKM and NUBM was amplified
using the primers listed in Table S1 in the supplemental material and
cloned into pGEM-T Easy (Promega). Knockout constructs were gener-
ated as described previously (38), replacing one allele with the T7 RNA
polymerase andNEO genes and the other with the Tet repressor andHYG
genes. After transfection and selection, the resulting BF lines were ana-
lyzed by PCR (testing for correct integration of the knockout constructs
and absence of the coding sequence) and Southern analysis to identify
those that lacked NUBM (nubm) or NUKM (nukm).
Native gel electrophoresis.Toprepare the organellar fraction, 1 108
to 2  108 BF or PF parasites were treated with a final concentration of
0.025% (wt/vol) digitonin in Hank’s balanced salt solution (HBSS; Invit-
rogen) supplemented with protease inhibitors (Roche), as described pre-
viously (34, 54). The organellar pellets were solubilized in 100 l ice-cold
HBSS with 1% dodecyl maltoside (DDM) and incubated on ice for 10
min. After centrifugation at 16,000 g for 10min at 4°C, the supernatant
was incubated with 1 U of RNase-free DNase I (Promega) and 10 mM
MgCl2 for 10 min on ice. Native gel electrophoresis of the DNase-treated
organellar lysates was performed according to published protocols (64,
65), with the following changes. To 80 l of lysate, we added 10 l of 1%
Ponceau S and 10 l of 50% glycerol for high-resolution clear native gel
electrophoresis (hrCNE) or 5 l of 5% Coomassie G-250, 5 l of 1%
Ponceau S, and 10 l of 50% glycerol for blue native gel electrophoresis
(BNE). Unless otherwise noted, 107 cell equivalents (approximately 20g
of protein) for BFs or 5  106 cell equivalents for PFs were loaded onto
precast NuPAGE bis-Tris 4 to 16% gradient clear native gels (Invitrogen).
For hrCNE, the cathode buffer was supplemented with 0.05% deoxy-
cholate and 0.02% dodecyl maltoside. For BNE, the cathode buffer was
supplemented with 0.05% Coomassie G-250, followed by a change to
0.005%Coomassie G-250 after 30min. Gels were run at 4°C, beginning at
150 V for 1 h and then at 300 V until most of the dye front ran off the gel.
Immunofluorescence, immunoblot, and immunoprecipitation
analysis. BFs were incubated in prewarmed HMI-9 medium with 60 nM
MitoTracker red CMXRos (Invitrogen) at 37°C for 30 min to stain mito-
chondria. The parasites were then washed, fixed in 3.7% paraformalde-
hyde (Sigma), and placed on poly-lysine-coated coverslips, before per-
meabilizing with 0.1% Triton X-100 in PBS. Slides were blocked with a
mixture of 5.5% FBS and 10% goat serum. Mouse anti-V5 monoclonal
antibody (MAb) was used at 5 g/ml, followed by fluorescein
isothiocyanate-labeled goat anti-mouse IgG2a (Southern Biotech) at 5
g/ml. Nuclei and kinetoplasts were stained with 4=,6-diamidino-2-
phenylindole (DAPI; Sigma). Coverslips were mounted using Prolong
antifade reagent (Invitrogen), and samples were viewed with a Delta Vi-
sion RT deconvolution microscope with an Olympus UPlan/Apo 100
1.35-numerical-aperture objective. Images were deconvolved using the
conservative ratio option; single deconvolved planes are shown. ForWest-
ern blots, protein samples (107 cell equivalents for BFs or 5  106 cell
equivalents for PFs) were resolved on precast SDS-polyacrylamide gels
(Bio-Rad) and then transferred onto nitrocellulose membranes. Native
gelswere equilibrated in 1 SDS running buffer for 30min before transfer
onto polyvinylidene difluoride (PVDF) membranes at 20 V overnight at
4°C. Blots were incubated in blocking buffer (Li-Cor Biosciences), fol-
lowed by either mouse anti-V5 MAb (Invitrogen) at 0.5 g/ml, mouse
anti-dihydrolipoamide dehydrogenase MAb 17 (2, 43) at 1:2,000, or rat
anti-HAMAb (Roche) at 1g/ml. Secondary goat anti-mouse IgG-IRDye
800CW, goat anti-rat IgG-IRDye 680CW (Li-Cor Biosciences), and goat
anti-rabbit IgG-IRDye 680CW (Li-Cor Biosciences) were detected upon
scanning on a Li-Cor Odyssey system. In some cases, anti-V5 MAb was
directly coupled to IRDye 800CW.
For coimmunoprecipitation analysis, crude organellar fractions were
prepared from 108 BFs expressing the proteins of interest as described
above and incubated with 100 l of 30 mg/ml rabbit IgG coupled to
magnetic beads, according to the manufacturer’s protocol (Invitrogen),
with 75 l of (10 mg/ml) anti-HA MAb 5D8 magnetic beads (MBL) or
with anti-HA MAb 1.11 (Covance) and protein G-coupled magnetic
beads. After 1 h at 4°C, the beads were washed three times in HBSS sup-
plemented with protease inhibitors and 0.1% DDM (34, 54) and then
eluted with SDS-PAGE sample buffer for immunoblot analysis. Aliquots
of the initial lysate and nonbound material were reserved for analysis as
well.
To obtain proteins for mass spectrometric analysis, solubilized crude
organellar fractions were prepared as described above from5 109 BFs
harvested from rats. We employed a V5 purification kit, following the
manufacturer’s protocol (MBL). Briefly, the sample (0.5 ml) was incu-
bated with 40 l of a 50% slurry of beads bearing anti-V5 MAb 1H6 and
washed three times. The bound complexes were eluted with 40 l of V5
peptide and subjected to native gel electrophoresis. After silver staining,
the band at the appropriate molecular mass was excised and provided to
the Fred Hutchison Cancer Research Center Proteomics Facility for tryp-
sin digestion and tandem mass spectrometry on an LTQ Deca (experi-
ment 1) or an LTQOrbiTrap (experiment 2) spectrometer. The resultant
spectra were analyzed by X! Tandem (15) and Mascot (45) software, and
statistical validation was conducted via Scaffold software (Proteome Soft-
ware), which utilizes the Bayesian algorithms of Peptide Prophet (30) and
Protein Prophet (37) software. High-abundance proteins such as glyco-
somal and cytoskeletal proteins were eliminated as candidates, and the
identified proteins were compared to those previously seen in cI in
PFs (1).
NADH dehydrogenase activity assays. For in-gel activity assays,
hrCNE gels were incubated in 10 ml NADH dehydrogenase assay buffer
(2.5mg/ml nitroblue tetrazolium, 100g/mlNADH, and 5mMTrisHCl,
pH 7.4) for30 min at 25°C (26). The gel was subsequently stained with
Coomassie R-250 to visualize the marker proteins.
For in-solution assays, an organellar preparation containing mito-
chondria was made as described previously (26). In brief, BF and PF
culture pellets containing 3  108 cells were lysed hypotonically. The
organellar pellets were solubilized in 100 l 1 M aminocaproic acid with
2%dodecylmaltoside supplementedwith protease inhibitors as described
above at 4°C for 30 min. The lysates were centrifuged at 16,000 g for 10
min at 4°C. The NADH dehydrogenase assay was carried out in a 500-l
reaction volume containing 10l of the clarified lysate in NDHbuffer (50
mM potassium phosphate buffer, pH 7.5, 1 mM EDTA, 0.2 mM KCN),
100 M NADH, and 20 M coenzyme Q2. The change in absorbance at
340 nmwasmeasured every 10 s for 2min; reactionswere linear for at least
10 min. A unit of activity was defined as the amount of enzyme that
catalyzes the oxidation of 1 nmol NADH min1, assuming an extinction
coefficient of 6.2 mm1 cm1. Specific activity was expressed in nmol
min1 mg1 of protein lysate.
RESULTS
Bloodstream forms and procyclic forms possess similarly sized
complexes containing putative cI subunits. Previous proteomic
analyses identified canonical and trypanosomatid-specific cI sub-
units from PFmitochondria (1, 43). To assess whether cI compo-
nents were present in BFs, monoclonal antibodies 52 and 63,
which bind conformational epitopes of unidentified proteins in cI
Respiratory Complex I in Bloodstream T. brucei
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subcomplex  (43), were used. These antibodies specifically
stained themitochondrion of BFs (see Fig. S1A in the supplemen-
tal material) and detected complexes of similar sizes in BFs and
PFs upon glycerol gradient fractionation (Fig. S1B), suggesting the
presence of cI-like complexes in BFs.
Native gel electrophoresis provides greater resolution than
glycerol gradients and has been successfully used to study bacterial
and mitochondrial cI from other systems (64, 65). C-terminally
taggedNUBMhas been successfully used to study bacterial cI (47).
Therefore, to avoid uncertainties using antibodies detecting un-
identified conformational determinants (and because attempts to
generate useful antisera directed against core subunits were not
successful), we combined these techniques to investigate the pres-
ence of cI in BF T. brucei. Biochemically, cI can be separated into
the hydrophobic  subcomplex and the  subcomplex, which can
be further separated into the hydrophilic  region and the hydro-
phobic  region (11, 32).We therefore generated BF lines express-
ing individual V5-tagged versions of core and accessory cI pro-
teins of the  and  subcomplexes. These include four core
proteins that reside in the hydrophilic part of the cI subcomplex
and participate in electron transfer, namely, NUBM (43), NUKM
(alias, NdhK in T. brucei [46]), NUAM, and NUHM (see Table 1
for nomenclature and details). We also cloned and expressed
V5-tagged versions of three conserved cI accessory subunits
(NB4M, NI8M, and one of two candidate NUEM proteins)
and a trypanosomatid-specific accessory protein (an acyl-CoA
synthetase/ligase-like protein [ACSL]) previously observed in
TAP-tagged pulldowns of cI subunits in PFs (1, 43). Addition-
ally, NI2M, a conserved cI accessory protein, and an LYR motif
protein that was observed in NI2M complexes from PFs were
tagged with V5. This LYR motif protein is related to human
LYRM4 and Saccharomyces cerevisiae ISD11 but, unlike T. brucei
Isd11 (Tb927.10.12000), does not appear to contribute to iron-
sulfur cluster biogenesis (44). For simplicity, we will refer to it as
LIR (LYR/Isd11 related). Core proteins of the  subcomplex are
encoded by kinetoplast DNA, precluding their analysis by this
approach.
Western blot analysis with anti-V5 antibody confirmed the ex-
pression of the tagged proteins in the transfected parasites (Fig.
1A). One major band migrating as predicted from the open read-
ing frame was usually seen when parasites were lysed directly in
SDS sample buffer. Each of these proteins was localized to the
mitochondrion in BFs by immunofluorescence analysis (Fig. 1B;
see Fig. S2 in the supplemental material).
To determine whether the tagged cI proteins exist in com-
plexes, BFs were lysed with digitonin and the organellar fraction
containing mitochondria was prepared for native gel analysis by
extraction with dodecylmaltoside to gently solubilize cI and other
membrane complexes. Following removal of insoluble material,
the proteins were separated by hrCNE on 4 to 16% gels and trans-
ferred onto PVDF membranes, which were then probed with
anti-V5 MAb. As summarized in Table 1 and shown in Fig. 2,
major bands averaging 740 kDa were detected in BFs expressing
FIG 1 Tagged putative cI subunits are expressed and localize to themitochon-
drion in BFs. (A) Western blot of V5-tagged proteins. Whole-cell lysates of
induced (Tet) and uninduced (Tet) BFs stably transfected with tagged cI
subunits were analyzed by SDS-PAGE (10% gel) and Western blotting using
mouse anti-V5 MAb. The predicted molecular masses of the full-length pro-
teins are as follows: NUKM, 23.1 kDa, ACSL, 59.0 kDa; NUBM, 55.3 kDa;
NUAM, 33.7 kDa; NUHM, 30.9 kDa; NI8M, 18.8 kDa; LIR, 23.7 kDa, NB4M,
83.4 kDa; NUEM, 42.5 kDa; and NI2M, 36.2 kDa, plus three V5 epitopes (5.4
kDa total). The mass (in kDa) and migration of marker proteins are indicated
on this and other figures. Except for NUBM, expression was driven by a T7
promoter which yielded higher expression upon induction with Tet but de-
tectable expression in the absence of Tet. (B) Immunofluorescence analysis.
The BF cell transfectants described above were induced with Tet, permeabil-
ized, and stained with mouse anti-V5 MAb (green), MitoTracker (red), and
DAPI (blue). In this and other experiments, strain 427 or its single-marker
derivative was used as WT BF parasite. DIC, differential interference contrast.
Bar 2 m.
FIG 2 Native gel analysis of BFs and PFs expressing tagged proteins. Western
blotting following hrCNE on 4 to 16% gels. Crude mitochondrial lysates ex-
pressing the indicated V5-tagged proteins were separated on native gels, blot-
ted, and probed with mouse anti-V5 MAb. Arrows indicate complexes of in-
terest. Except as noted, samples are from BFs. WT, wild-type BF (strain 427).
Surve et al.
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the V5-tagged -subcomplex protein NUBM, NUHM, or NB4M,
and a similarly sized doublet was seen for NI8M. LIR-V5 and
NI2M-V5 complexes averaged 855 kDa (Fig. 2). The size of the
complexes did not vary between BFs and PFs, as revealed in par-
asites expressing NUBM-V5 or LIR-V5 (Fig. 2). Faster-migrating
species (seen, for example, for NUBM-V5 and LIR-V5) may rep-
resent partially assembled complexes. To confirm that the intact
tagged proteins were part of the observed complexes, lanes from
selected native gels were subjected to second-dimension SDS-
PAGE, followed by Western blot analysis with anti-V5 antibody.
At the position of the complex in the first dimension, the second
dimension showed tagged proteins at the predicted molecular
mass (see Fig. S3 in the supplemental material).
The remaining tagged subunits, NUAM, NUKM, NUEM, and
ACSL, all of which are cI proteins, did not show specific bands
that comigrated with the 740-kDa  subcomplex but, rather, mi-
grated as smears with some fainter bands (Fig. 2 shows the exam-
ple ofNUKM; see also Fig. S4 in the supplementalmaterial and the
summary in Table 1). NUKM-V5 expressed in PFs also showed a
smeared pattern on hrCNE (data not shown). Recent work ex-
pressing TAP-tagged NUKM in PFs also failed to detect assembly
into a complex (1). These findings suggest poor assembly or re-
tention of these C-terminally tagged proteins or possibly that the
tag could be obscured within the complex.
To determinewhether the observed complexes containedmul-
tiple cI proteins as predicted, we performed coprecipitation anal-
ysis on BFs expressing NUHM-V5 alone or along with NUBM-
TAP or with LIR-HA (representing the smaller and larger
complexes). Similar analyses were performed on parasites ex-
pressing NI2M-V5. The lysates were incubated with IgG beads
(which capture TAP-tagged proteins) or anti-HA beads. Analysis
of the bound material demonstrated that NUHM-V5 was pulled
down by IgG beads when NUBM-TAP was expressed, but not in
its absence (Fig. 3B). NUHM-V5 did not coprecipitate with
LIR-HA (Fig. 3A). Conversely,NI2Mwas pulled downby anti-HA
only in the presence of LIR-HA (Fig. 3C) and was not captured by
IgG beads in the presence (or absence) of NUBM-TAP (Fig. 3D).
Thus, NUHM and NUBM are in the same complex, presumably
cI (or subassemblies thereof), while LIR and NI2M are associ-
ated with a distinct complex, presumably cI.
Multiple cI-subcomplex proteins are expressed in BFs.The
composition of the LIR complex in PFs was recently described (1).
The similar size of this complex in PFs and BFs (Fig. 2) suggested
that their compositions are likely to be similar. To determine
whether the proteins observed in the PF LIR complex are also
present in the BF LIR complex, we immunoprecipitated LIR-V5
from BFs, eluted the complex from beads with V5 peptide, and
subjected the eluate to hrCNE (see Fig. S5 in the supplemental
material). The gel piece containing the purified complex was di-
gested with trypsin and subjected to mass spectrometry. Multiple
peptides were detected for 11 of 15 proteins known to be associ-
ated with the LIR complex in PFs (1) (Table 2). Further sequence
analysis suggests that in addition to NI2M, one of these proteins is
another conserved cI subunit, NIDM (see Fig. S6 in the supple-
mental material). Two proteins also proposed to be part of cI (1),
although not mapped to a specific subcomplex in that study, were
also observed with high confidence. No cI proteins were de-
tected, other than a single peptide of acyl carrier proteinwhichwas
previously detected in both subcomplexes (1).While using tagged
NUBM to capture the 740-kDa complex from BFs suffered from
yields too low to allow similar studies, the native gel analysis, co-
precipitation studies, and mass spectrometry together indicate
that the 740-kDa and 855-kDa complexes represent the  and 
subcomplexes of BF cI, respectively.
TaggedNUBMandLIRdonot assemble into complexes inT.
evansi. If the complexes that we detected are indeed cI related,
then they should be altered in trypanosomes lacking mitochon-
drially encoded subunits of cI. Therefore, we examined whether
FIG 3 Coprecipitation analysis. Lysates from BFs expressing NUHM-V5 or NI2M-V5 expressed alone or with NUBM-TAP or LIR-HA were prepared.
NUBM-TAP was pulled down by IgG beads (B and D). LIR-HA was pulled down by anti-HAMAb 1.11 and protein G beads (A) or anti-HAMAb 5D8 directly
coupled to magnetic beads (C). After electrophoresis on 4 to 12% SDS-polyacrylamide gels, blots were prepared and probed with rabbit anti-goat IgG (to detect
TAP tags), rat anti-HA plus IRDye-labeled goat anti-rat IgG, and directly labeled anti-V5 MAb (except for panel A, for which anti-V5 MAb plus labeled goat
anti-mouse IgG was employed). ML, crude mitochondrial lysate; FL, flowthrough; IP, pulled-down samples; 10, 10-fold more cell equivalents were loaded;
asterisks; coprecipitation of tagged subunits in panels B and C; brackets in panel A, IgG light chain (L).
Respiratory Complex I in Bloodstream T. brucei
February 2012 Volume 11 Number 2 ec.asm.org 187
NUBM and LIR could assemble into complexes in the closely re-
lated dyskinetoplastic trypanosome T. evansi (strain AnTat 3/3),
which has evolved to lack all mitochondrially encoded protein
coding genes, including the eight genes predicted to encode core
subunits of cI (53) (relocalization to the nuclear genome has been
ruled out in AnTat 3/3 [16]). We expressed V5-tagged LIR and
NUBM inT. evansi and analyzed the samples by immunoblotting.
Although the proteins were expressed, as seen by SDS-PAGE and
Western blotting, they were not assembled into the complexes
seen in T. brucei (Fig. 4). The most likely explanation for this
observation is that subunits critical for assembly or stability of the
cI subcomplexes aremissing inT. evansiAnTat 3/3. The predicted
nuclearly encoded cI subunits are present and, on average, show
99% sequence identity between the T. brucei reference genome
strain 927 and T. evansi strain STIB805 (A. Schnaufer, unpub-
lished data). For example, LIR is identical in amino acid sequence
in both, whereas NUBM shows one amino acid change (plus an
additional change in the second allele) in T. evansi. Thus, these
data suggest that both the NUBM complex and the LIR complex
require products encoded in the mitochondrial genome for their
assembly or stability.
Electron transfer in cI is not essential in proliferating BFs.
Having established that cI-related complexes are present in T.
brucei BFs, we next assessed whether cI activity is important in
BFs. The flavoprotein NUBM is the first protein to receive elec-
trons from NADH, whereas the iron-sulfur cluster protein
NUKM is the last protein in the redox chain and passes electrons
to ubiquinone (24). Therefore, to assess whether electron transfer
TABLE 2 LIR complexa proteins detected in BFs
System identifier Name/GeneDB annotation
Mol wt
(103)
No. of unique
peptides
Protein
probability (%)
Subunits of cI detected (99%
probability)
Tb927.4.4300 SET domain SFb 63.1 10 99
Tb927.7.3910 Nucleoside triphosphate hydrolase SF 57.6 6 99
Tb927.8.2530 Copper chaperone SF 13.3 2 99
Tb927.8.5560 S-Adenosylmethionine-dependent methyltransferase SF 60 18 99
Tb09.160.4910 Monooxygenase, putative (FAD/NADP binding domain) 66.2 12 99
Tb09.244.2840 Hypothetical protein, trypanosomatid specific 23.2 13 99
Tb927.10.1160 Hypothetical protein, trypanosomatid specific 17.5 9 99
Tb11.01.1690 NIDM 30.3 5 99
Tb11.01.7090 LIR 23.7 4 99
Tb11.01.7460 NI2M 36.3 6 99
Tb11.02.2070c Long-chain fatty acid–CoA ligase protein, putative 73.4 13 99
Candidate subunits of cI detected,
subcomplex not defined
Tb927.8.6960 FAD/NADP binding domain SF 45.4 3 99
Tb927.10.5500 Hypothetical protein, trypanosomatid specific 41.4 8 99
Subunits of cI, presence not
confirmedd
Tb927.3.860 Acyl carrier protein 16.5 1 98
Tb927.4.440 Hypothetical protein, trypanosomatid specific 13.8 1 58
Tb09.160.0390 Monooxygenase, putative (FAD/NADP binding domain SF) 51.4 1 58
Tb09.211.2780 Hypothetical protein, trypanosomatid specific 12.3 1 58
a As defined in reference 1.
b SF, superfamily.
c This protein is distantly related to the -subcomplex protein ACSL.
d No mitochondrially encoded candidate subunits were detected in this or previous studies (1, 43).
FIG 4 NUBM-V5 and LIR-V5 complexes are not formed in T. evansi.
NUBM-V5 and LIR-V5 were expressed in BF T. brucei (Tb) and T. evansi (Te)
upon Tet induction, and cell equivalents were probed with anti-V5 MAb.
(Top) Native gel Western blot, with arrows marking complexes of interest;
(bottom) SDS-PAGEWestern blot.
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in cI is important to BFs, we generated deletion mutants of these
core proteins by homologous recombination (see Fig. S7A in the
supplemental material). Generation of the double knockouts
nubm and nukm did not require the presence of a comple-
menting gene. Southern blot analysis showed the absence of the
coding sequence and the presence of the expected integration
events innubm andnukm lines (see Fig. S7B in the supplemen-
tal material). Thenubm andnukm BFmutants were compared
with wild-type BFs for their ability to grow in vitro in standard
medium. Cell counts over a period of 7 days indicated no differ-
ence in growth rate of themutants compared to the parental wild-
type parasites (Fig. 5A).
We next tested whether the loss of cI electron transfer affected
parasite growth in vivo. Mice were injected intraperitoneally with
wild-type, nubm, and nukm parasites. Parasitemias were
scored until the number reached 108, at which point the animals
were euthanized. In all cell lines, parasitemia increased with vir-
tually identical rates (Fig. 5B). These studies demonstrate that the
electron transport function of T. brucei cI is not essential or even
important for growth or virulence in BFs, at least not under these
experimental conditions.
The availability of these null mutants allowed us to assess
whether the NUBM and LIR complexes required the presence of
these core cI subunits for proper assembly. We expressed LIR-V5
in thenubm andnukm lines andNUBM-V5 in thenukm line.
There were no discernible differences in the size of the LIR com-
plex in these lines compared to wild type (Fig. 5C), indicating that
neither NUBM nor NUKM is required for its assembly. Similarly
NUKM appears not to be required for assembly of the NUBM
complex, even though the two core proteins typically participate
in electron transfer and reside in the hydrophilic  portion of the
 subcomplex of cI. We suggest that the resolution of our gel
system is not sufficient to detect the loss of NUKM (23 kDa) from
the NUBM complex. Because NUKM-V5 did not assemble into
complexes, we were unable to perform the reverse experiment in
the nubm line.
In-gel NADH dehydrogenase activity in T. brucei is not due
to cI. In-gel catalytic assays are standardly used to detect cI NADH
dehydrogenase activity in many systems (9, 65, 66). Such assays
have led to reports of cI activity in PF T. brucei and in Phytomonas
serpens (12, 26).Ournubm andnukmmutant lines provided an
opportunity to determine whether the reported activity can be
traced to cI in BFs.We also examined dyskinetoplastidmutantsT.
brucei EATRO 164 dk and T. evansi AnTat 3/3 as controls, since
they lack all mitochondrially encoded subunits of cI. Solubilized
crude organellar preparations were separated by hrCNE and
stained for NADH dehydrogenase activity using the nitrotetrazo-
lium blue electron acceptor. In PFs and all of the BF samples,
including nubm, nukm, and the dyskinetoplastic strain T. bru-
ceiEATRO164dk, activitywas predominantly positioned at500
kDa in 4 to 16% hrCNE gels (Fig. 6A), clearly distinct from the
position of the cI complex at 740 kDa on such gels (Fig. 2).
Similar results were obtained forT. evansi (data not shown). Thus,
this activity is not due to cI. The migration of the major NADH
dehydrogenase changed with gel conditions. On blue native gels,
as used in previous work (26), the major activity bandmigrated at
530 kDa (data not shown), while itmigrated at650 kDa in 3 to
12% hrCNE gels (see Fig. S8 in the supplemental material). On
some gels, we observed an additional faint activity band that mi-
grated significantly more slowly than the 1,048-kDa marker in
each sample (WT, nubm,nukm, and PF), indicating that it too
is not cI (Fig. S8).
Despite its common use, the nitroblue tetrazolium electron
acceptor is not specific for cI. Complexes containing dihydrolipo-
amide dehydrogenase can also be detected on native gels using
NADH and nitroblue tetrazolium as substrates (67). Indeed,
immunoblotting of the 4 to 16% native gel with anti-
dihydrolipoamide dehydrogenase (Tb11.01.8470) MAb 17 re-
vealed a band at500 kDa, the same size as the NADH dehydro-
genase activity band (Fig. 6B). As the dihydrolipoamide
dehydrogenase subunit is potentially shared between four com-
plexes (glycine cleavage complex, 2-oxoglutarate dehydrogenase,
branched-chain -ketoacid dehydrogenase, and pyruvate dehy-
drogenase), the observed activity likely results from one of those
complexes.
Complex I does not contribute significantly to NADH:
ubiquinone oxidoreductase activity in BFs. Because the in-gel
assay used a general electron acceptor, a specific NADH:ubiq-
uinone oxidoreductase activity assay was performed in wild-type,
nubm, and nukm BF lines using the electron acceptor coen-
FIG 5 BFs lacking cI subunits essential for electron transport are viable in vitro and in vivo and formNUBM and LIR complexes. (A) In vitro growth assay. Null
mutants nubm and nukm were compared to the parental wild-type strain for growth in vitro. Each point on the lines is the mean of triplicate cultures (the
standard deviationwas too small to depict). Similar results were obtained in a second experiment. (B) In vivo growth assay. Following injection into groups of five
mice, the parasitemia was measured daily. Data are represented as mean SEM. Similar results were obtained in a second experiment. (C) Native gel Western
blot. LIR-V5 was expressed in the nubm and nukm lines, and NUBM-V5 was expressed in the nukm line. The blots were probed with anti-V5. Complexes
of interest are indicated by the arrows.
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zymeQ2. Crudemitochondrial pellets were solubilized in dodecyl
maltoside, and the cleared lysates were used for the assay (no ac-
tivity was observed in the pellet fraction). As a control, we utilized
PFs and observed a similar amount of activity compared to that
reported by Fang et al. (21), which is about 4-fold higher than that
reported by Verner et al. (61). As shown in Fig. 6C, a low level of
activity was reproducibly observed in BF lysates, measuring ap-
proximately 25% of that seen in PFs at a mean of 30.4 6.2 nmol
min1 mg1 protein. In three separate experiments, we observed
no reduction inNADH:ubiquinone oxidoreductase activity in the
nubm ornukmmutant line compared to thewild-type parental
line (Fig. 6C), with an average of 34.4 8.6 and 29.7 10.2 nmol
min1 mg1 protein, respectively. Considering the critical role of
NUBM and NUKM proteins in cI-mediated transfer of electrons
fromNADH to ubiquinone, the data demonstrate that little if any
cI activity is present in BFs and indicate that the low level of
NADH:ubiquinone oxidoreductase activity observed in this assay
is due to other enzymes.
DISCUSSION
On the basis of low levels of NADH:ubiquinone oxidoreductase
activity and its low sensitivity to the cI inhibitor rotenone, the
presence and functionality of cI in T. brucei have been debated
(40). Comparative genomics recognized the homologues of 12
core and 7 conserved accessory cI subunits in the nuclear and
mitochondrial genomes of T. brucei (29, 40), and in PFs, 4 cI core
subunits and the 7 conserved accessory subunits have been iden-
tified by proteomic analysis (1, 29, 43). Recent work suggests that
cI contributes about 20% of the NADH dehydrogenase activity in
PFs, even though it appears not to be essential (61). Since there is
evidence that several mitochondrially encoded cI subunit mRNAs
are fully edited preferentially or even exclusively in BFs (31, 48,
56), we tested the hypothesis that cI has an important role in this
stage of the parasite’s life cycle. In this report, we provide the first
evidence that the two cI subcomplexes,  and , are present in the
pathogenic BF stage. However, null mutants for key catalytic sub-
units showed normal growth under in vitro and in vivo conditions,
raising the question of why T. brucei invests considerable energy
into the biogenesis of this largest complex of the respiratory chain.
The  subcomplexes from BFs and PFs comigrated on hrCNE,
as did the  subcomplexes, suggesting that their subunit compo-
sitions are quite similar in both stages. Indeed,mass spectrometric
analysis of LIR-V5 pulldowns from BFs contained multiple pro-
teins observed in similar pulldowns from PFs (Table 2; see also
reference 1). While a few accessory proteins detected in PF cI
remain unconfirmed to be part of BF cI, this might reflect the
limited amounts of protein available for analysis rather than a true
difference. It is interesting that there are no data as yet that
strongly support the association of the two subcomplexes in either
stage. The twomost extreme explanations for the lack of evidence
for physical association are that (i) the subcomplexes are associ-
ated in vivo but the structure is disturbed by the experimental
conditions or (ii) the LIR complex is distinct from cI. In defense of
the first proposal, the physical separation of cI into subcomplexes
is well-known (11, 32). Although the conditions that we used are
similar to those employed to study cI from other species, the com-
plete T. brucei cI complex might be more susceptible to dissocia-
tion than is typical or undergo only limited assembly into the
complete complex in vivo. With respect to the second proposal,
the proteins that coprecipitated with tagged LIR here and in PFs
(1) included only two proteins that are identifiable members of
cI, NI2M and NIDM. Two proteins important for the proton-
pumping activity of cI are not identifiable via bioinformatic anal-
ysis, raising the intriguing possibility that the LIR complex repre-
sents a diverged version of the hydrophobic arm of cI that has
adopted additional subunits and functions.
Our data suggest that mitochondrially encoded proteins are
required for the assembly or maintenance of the NUBM-V5- and
LIR-V5-containing complexes. T. brucei NUBM-V5 and LIR-V5,
when expressed inT. evansi, which lacksmitochondrially encoded
proteins, did not assemble in large complexes. It is unlikely that
this finding reflects sequence divergence between T. brucei and T.
evansi since their LIR and NUBM protein sequences show 100%
and 99% identities, respectively. T. brucei mitochondrial DNA
is predicted to encode at least eight core cI subunits, including
ND8 (NUIM) andND9 (NUGM), components of the hydrophilic
arm, thus explaining why the NUBM complex does not properly
form in T. evansi. Obvious candidates for mitochondrially en-
FIG 6 In-gel NADHdehydrogenase activity is unaltered inNUBMorNUKMdeletionmutants and dyskinetoplasticT. brucei. (A) In-gel activity assay following
hrCNE on 4 to 16% gels. (B) The majority of in-gel NADH dehydrogenase activity comigrates with a dihydrolipoamide dehydrogenase (DLDH)-containing
complex. Different lanes from the same gel were analyzed for NADH dehydrogenase activity (left) and by Western blotting using anti-DLDH MAb 17. (C)
Complex I does not contribute to specific NADH:ubiquinone oxidoreductase activity in BFs. Lysates from PFs as well as WT, nubm, and nukm BFs were
assayed for NADH:ubiquinone oxidoreductase activity using the specific electron acceptor coenzyme Q2. The specific activities from three independent
experiments are expressed as the mean SEM in nmol1 min1 mg protein.
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coded proteins essential for the LIR complex are themitochondri-
ally encoded ND4 and ND5 subunits of cI and the four uniden-
tified reading frames.
The NUBM and the NUKM proteins are essential for cI elec-
tron transport activity (8, 19, 33). The two cI subunit-knockout
strains, nubm and nukm, were indistinguishable from wild
typewith respect to growth in vitro and virulence in vivo. The latter
finding argues that the lack of a requirement for cI is not simply
the result of long-term culture in replete medium. In addition,
comparison of NADH:ubiquinone oxidoreductase activity in
crude mitochondrial fractions showed no significant differences
between wild type, nubm, and nukm parasites (Fig. 6). Simi-
larly, none of the bands showingNADHdehydrogenase activity in
the in-gel assay corresponded with the cI complex. Thus, elec-
tron transport activity of cI is not essential or even detectable in
slender BFs. These data indicate that cI is not catalytically active in
this developmental stage or is present in very low abundance.
Although there is now evidence for the presence of cI-like sub-
complexes in two life-cycle stages of T. brucei, cI functions in the
parasite remain enigmatic. In Plasmodium and Saccharomyces
cerevisiae, the absence of cI function reflects the loss of all cI core
genes, a situation dramatically different from that in trypano-
somes. Our comparison of nucleotide substitution rates in genes
encoding bona fide cI subunits of T. b. brucei and T. congolense
(using the Nei-Gojobori model [36] in theMEGA5 software [58])
shows that the ratio of synonymous and nonsynonymous changes
is similar to that of known essential genes (see Table S2 in the
supplemental material). These findings indicate that purifying se-
lection is acting to maintain the functionality of these genes in
African trypanosomes, pointing to an important role at some
point in the parasite life cycle. Given that the NADH:ubiquinone
oxidoreductase activity of cI is irrelevant in slender BFs and PFs,
when might cI be important? The strain that we used does not
develop into transitional stumpy BFs, but Bienen and coworkers
proposed a critical role for cI in generating the mitochondrial
membrane potential and possibly ATP synthesis in that stage (4).
In a high-throughput RNAi study (3), about 30% of the cI and
cI proteins appeared to be important either in BFs in the process
of differentiating to PFs or under all conditions (slender BFs, dif-
ferentiating BFs, and PFs). Interestingly, five subunits were iden-
tified only in the differentiation experiment.However, none of the
hits under any condition were core subunits, and the majority
were trypanosomatid specific. Of course, cI function could be im-
portant in other insect stages, such as epimastigotes and metacy-
clic forms, which remain relatively inaccessible and understudied.
Nonetheless, the evolutionary conservation of the identified bona
fide subunits of cI in among trypanosomatids such as T. brucei, T.
congolense, T. cruzi, or Leishmania spp. indicates that certain, but
possibly varying, functions of cImay have been retained across the
trypanosomatid order. Interestingly, L. tarentolaewas reported to
lose minicircles required for editing of mitochondrially encoded
cI mRNAs after prolonged culture of the promastigote stage (59),
supporting the notion of a stage-specific role. In contrast, mito-
chondrial DNA deletions affecting cI subunits in T. cruzi lineages
were taken as evidence that the complex does not have an impor-
tant role in that organism (10). A potential role of cI that is not
directly related to its classical enzymatic function in electron
transfer and proton translocation is its association with certain
accessory factors. For example, acyl carrier protein has been found
to be associated with cI in PFT. brucei (43) and some other organ-
isms (23), and this protein is essential in BF T. brucei (13). How-
ever, the viability and virulence of dyskinetoplastic T. evansi par-
asites, which do not appear to assemble these complexes, suggest
that any such functions do not require assembly of those subunits
into the full complex or that such a requirement has been circum-
vented in these parasites.
Althoughwe did not find evidence for any contribution of cI to
NADH:ubiquinone oxidoreductase activity in BF T. brucei, this
activity is clearly present, albeit at reduced levels compared to PF
cells (Fig. 6C). The alternative NADH dehydrogenase (NDH2)
activity is capable of using the same electron acceptor and may
thus be the major cause of this activity in BF (20, 61). Studies are
under way in our laboratories to test the importance of NDH2 to
wild-type and cI-deficient mutant T. brucei parasites. Coinciden-
tally, our work helps to explain why BF T. brucei may have a re-
quirement for a mitochondrial NADH dehydrogenase activity in
the first place. The in-gel activity assay showed a prominent 500-
kDa band in lysates from PF, BF wild-type, nubm, and nukm
samples (Fig. 6A).While this activity was previously interpreted to
be that of T. brucei cI (26), our data suggest that it can be ascribed
to a complex containing dihydrolipoamide dehydrogenase (Fig.
6B). A good candidate is the glycine cleavage complex, an activity
likely essential for 1-carbon metabolism in T. brucei (35, 51). Mi-
tochondrial NADHdehydrogenase activity would therefore be re-
quired to regenerate NAD consumed by dihydrolipoamide dehy-
drogenase.
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